Alan m

Personal Information


Columbia College, Columbia University, New York A.B. 1975 Southern Illinois University, Edwardsville, Illinois M.S. 1976 New York Medical College, Valhalla, New York M.D. 1980
Professional Training/Post-Graduate Training
1985 to present: Gastroenterology Consultants, P.C. (formerly Drs. Cohen & Fixelle, P.C.) 1983 to 1985: Emory University School of Medicine Fellowship – Specialty Training in Digestive Diseases Internship/Residency - Internal Medicine

Licenses and Board Certifications

Subspecialty in Gastroenterology November 1985
Academic Teaching Experience
1985 to present Clinical Instructor of Medicine, Division of Digestive Diseases, Emory University School of Medicine 2007 to present Preceptor for specialty elective rotation for Emory Family Practice
Staff Positions/Hospital and Ambulatory Surgery Center Privileges

Status: Active staff – hospital closed 12.2006 Chief of Gastroenterology/Director-GIDU Chairman, Patient Education Committee 2001- 2006 Chairman, Department of Medicine 1995-96 St. Joseph’s Hospital, Atlanta, Georgia Northside Hospital - Atlanta Main Campus Operative and Surgical Procedures Committee 2006 - present Section Chief, Division of Gastroenterology 2010 - present Promina-Gwinnett Health System Hospitals Gwinnett County, Georgia Status: resigned due to inactivity Status: Active Staff (based on Northside Hospital –Atlanta) Section Chief, Division of Gastroenterology 2010 - present Status: Staff gastroenterologist/endoscopist Society Memberships
 American College of Physicians/ASIM  American Gastroenterology Association  Fellow, American College of Gastroenterology  American Society of Gastrointestinal Endoscopy  Georgia Society of Gastroenterology & Endoscopy  Atlanta Gut Club (now defunct)  American Liver Foundation  Crohn’s and Colitis Foundation of America
Academic Honors and Awards
 Recipient of 1st Annual Sam Schatten Life Saver Award, Atlanta, GA –  Top Doctor, U.S. News & World Report – October 2011
Top MD, Consumers’ Checkbook
 Profiled in Atlanta Super Doctors 2012 by
Clinical Specialty and Interests
Gastroenterology: Biliary Tract Disease, Gastrointestinal Functional &
Motility Disorders, Hepatology & Liver Transplantation, Inflammatory  Clinical Interests: Delivery of Health Care; Gastroenterology;
Endoscopy; Hepatitis; Inflammatory Bowel Diseases; Colonic Neoplasms;
Clinical Trial Experience

 Bard Gastric Balloon Prototype: Placement of intra-gastric balloon- placebo controlled study in obese human subjects, ca. 1984 - Emory University School of Medicine  Multi-center Study in Use of Asacol in patients with inflammatory bowel  Compassionate Use of Interferon plus Ribavirin in human patients with  IFN/ribavirin treatment with high dose daily induction therapy followed by  PEG-Intron/ribavirin therapy in patients who relapsed with HCV (Lawitz)  Weight-based dosing PEG-Intron/ribavirin in patients with HCV  Comparison of Two Doses of PEG-Interferon alfa-2b in Combination with Ribavirin for Treatment of Chronic Hepatitis C Patients (Lee)  Multicenter Hepatitis C study (PEG-Intron/Rebetol) (Jacobson)  Irritable bowel syndrome studies- various subgroups with alosetron  GERD therapy studies - various therapeutic agents and indications- clinical  Chronic constipation study- colonoscopy evaluation pre-treatment
Public Speaking Credentials

 Served as local and national consultant/speaker for numerous pharmaceutical companies, including Eli Lilly, Schering, TAP, Novartis,  Grand Rounds, Board Review topics and CME lectures at hospital-based educational programs- variety of subjects in the field of gastroenterology  Didactic lectures delivered to Emory Physician Assistant program and  Preceptor/subspecialty rotation advisor to Emory Family Practice residents


Microsoft word - form6 application form complete.doc

Poisons Act 1971 Section 27 Poisons Regulation 2002 62(2)(a) APPLICATION FOR A LICENCE TO SELL OR SUPPLY CERTAIN SUBSTANCES To the Minister for Health and Health Services I, . (name, address and nature of business) hereby apply for a licence/renewal of licence to sell or supply the following substances to which Section 27 of the Poisons Act 1971 applies: SCH

Wetenschappelijke bijsluiter

Samenvatting van de Kenmerken van het Product 1. NAAM VAN HET GENEESMIDDEL REMINYL 4 mg omhulde tabletten REMINYL 8 mg omhulde tabletten REMINYL 12 mg omhulde tabletten 2. KWALITATIEVE EN KWANTITATIEVE SAMENSTELLING Elke REMINYL 4 mg - tablet bevat 4 mg galantamine (als hydrobromide). Elke REMINYL 8 mg - tablet bevat 8 mg galantamine (als hydrobromide). Elke REMINYL 12 mg

Copyright © 2011-2018 Health Abstracts